IMARC Group, a leading market research company, has recently releases report titled “Stem Cell Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global stem cell manufacturing market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big is the Stem Cell Manufacturing Market?
The global stem cell manufacturing market size reached US$ 12.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.
What are Stem Cell Manufacturing?
Stem cells are unique, multifaceted cells that develop into different cell types, including muscle, blood, and brain cells. They are commonly obtained from blood, bone marrow, embryo, umbilical cord, and placenta. They are cultured and multiplied in laboratory settings, providing an abundant supply for various applications. They are extensively researched for their efficacy in treating multiple conditions, such as neurodegenerative diseases, diabetes, and heart disease. They are cryopreserved to maintain their viability and are extensively used for human disease modeling, drug discovery, gene therapy, and tissue engineering. Besides this, they help decrease the need for organ donations and reduce the time patients spend on transplant waiting lists.
Request Free Sample Copy of This Report: https://www.imarcgroup.com/stem-cell-manufacturing-market/requestsample
What are the growth prospects and trends in the stem cell manufacturing industry?
The rising prevalence of chronic and degenerative diseases worldwide represents one of the key factors catalyzing the demand for efficient stem cell manufacturing processes. Additionally, the increasing awareness about the potential of regenerative medicine and the growth of the global aging population, who are more susceptible to chronic illnesses, is favoring market growth.
Apart from this, advancements in biotechnology are leading to improved manufacturing techniques. Furthermore, continuous investments in research and development (RD) activities, coupled with growing governmental support for stem cell studies, are offering a favorable market outlook.
Moreover, the emergence of induced pluripotent stem cells is positively influencing the market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
- Consumables
- Culture Media
- Others
- Instruments
- Bioreactors and Incubators
- Cell Sorters
- Others
- Stem Cell Lines
- Hematopoietic Stem Cells (HSC)
- Mesen****al Stem Cells (MSC)
- Induced Pluripotent Stem Cells (iPSC)
- Embryonic Stem Cells (ESC)
- Neural Stem Cells (NSC)
- Multipotent Adult Progenitor Stem Cells
Breakup by Application:
- Research Applications
- Life Science Research
- Drug Discovery and Development
- Clinical Application
- Allogenic Stem Cell Therapy
- Autologous Stem Cell Therapy
- Cell and Tissue Banking Applications
Breakup by End User:
- Pharmaceutical Biotechnology Companies
- Academic Institutes, Research Laboratories and Contract Research Organizations
- Hospitals and Surgical Centers
- Cell and Tissue banks
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Anterogen Co. Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, FUJIFILM Holdings Corporation, Lonza Group AG, Merck KGaA, Sartorius AG, Takara Bio Inc. and Thermo Fisher Scientific Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
